Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000 - RVMD News | RalliesRevolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000
R
RVMD• Anthony Mancini share sale
- Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,764 common shares on Sep. 18, 2026 at USD 196.94.
- Direct holdings fell to 40,352 shares following the transaction.
- Sale executed under a Rule 10b5-1 trading plan adopted on June 11, 2026.
•
